Antibody Discovery and Affinity Maturation Platform

Antibody/Biologics R&D Services

Hmoe / CRO Services / Antibody/Biologics R&D Services / Antibody Discovery and Affinity Maturation / Antibody Discovery and Affinity Maturation Platform

Viva Biotech has a team of experienced antibody discovery scientists and a comprehensive antibody discovery platform. Using hybridoma technology, phage display, and AI-assisted design, we provide antibody discovery and optimization services from a variety of sources, including human, mouse, rabbit, alpaca and camel. We have been providing high-quality antibody discovery services to large pharmaceutical companies and biotech companies in China and around the world for many years.

Phage Display Platform

A Proprietary Naïve Human scFv Phage Display Library(In-house)

Case study: Phage Display
Hybridoma Platform

Case Study: McAb Generation by Hybridoma Technology

Case Study: GPCR

Rabbit Monoclonal Antibody: Hybridoma Approach/scFv Library

Case study-Against Soluble Protein
Nanobody Discovery Platform
Viva High Performance Clusters

Complete Hardware Facility Constructions

Intel® Xeon® Gold 5318Y processor

NVIDIA® A100 Tensor Core GPU

Intel® Xeon® Silver Memory RAM and SSD

20G IB Switch

Extendable Cabinet Unit

GPU workstations -NVIDIA Quadro RTX5000

Xeon Gold 6248R 3.0G

High Performance Clusters Enable

Ultra-long MD simulations

Routine FEP calculations

Deep-learning augmented predictions

Generative AI models
Bispecific Antibody Platform

Viva Biotech has entered into a license agreement with Lonza to obtain access to Lonza's bYlok® bispecific pairing technology. This access significantly enhances Viva Biotech's capabilities in large molecules by facilitating the design and production of bispecific antibodies. Lonza's bYlok® technology platform effectively addresses the challenge of heavy-light chain mispairing and enhances the production efficiency and quality of bispecific antibodies. Lonza's bYlok® technology platform effectively addresses the mispairing problem of heavy/light chains, enhancing the production efficiency and quality of bispecific antibodies.

Online Message

After receiving your message, our professional team will contact you shortly.

Area of Interest

CRO Drug R&D Services

CDMO R&D and Production Services

EFS Investment＆Incubation Business

Media Cooperation

Investor Relations

Other

How Did You Hear About Us?

Search Engine (Google, Bing, Yahoo, etc)

Conferences/Events

Social Media

LinkedIn

Word of Mouth

Other

For more information about

“Antibody Discovery and Affinity Maturation”, please contact our team.